Clearbridge BioMedics has introduced the ClearCell FX technology, which can detect circulating tumor cells without the need for antibodies or other labeling techniques, this article says. The system, co-developed with Cambridge Consultants, incorporates a tiny device called the CTChip FR that employs fluid dynamics to isolate CTCs from other cells in blood for further analysis.
Clearbridge's device can detect CTCs without antibodies
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||